Investing, stocks, commodities, crypto and everything in between. This biweekly podcast with a focus on exchange-traded funds will guide you through the financial markets in Asia and beyond. Sponsored by HKEX.

Investing, stocks, commodities, crypto and everything in between. This biweekly podcast with a focus on exchange-traded funds will guide you through the financial markets in Asia and beyond. Sponsored by HKEX.

Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.

Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.

Votes & Verdicts

Tiger Money (Sponsored Content)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/743c9b07-0d06-4914-b0e9-b1f5017c3e64/transcript

The US presidential election on Nov. 5 will likely have significant effects on the financial-services industry, from the Basel III Endgame’s potential 9% hike in capital requirements for banks like JPMorgan, Bank of America, Citigroup and Goldman Sachs to increased debt requirements for midsized lenders such as PNC and U.S. Bancorp. As part of Bloomberg Intelligence’s election webinar series throughout October, BI analysts Nathan Dean, Elliott Z Stein, Alison Williams, Herman Chan and Arnold Kakuda discuss the implications of the election on the US banking industry in this edition of the Votes and Verdicts podcast.

The US presidential election on Nov. 5 will likely have significant effects on the financial-services industry, from the Basel III Endgame’s potential 9% hike in capital requirements for banks like JPMorgan, Bank of America, Citigroup and Goldman Sachs to increased debt requirements for midsized lenders such as PNC and U.S. Bancorp. As part of Bloomberg Intelligence’s election webinar series throughout October, BI analysts Nathan Dean, Elliott Z Stein, Alison Williams, Herman Chan and Arnold Kakuda discuss the implications of the election on the US banking industry in this edition of the Votes and Verdicts podcast.

Harris, Trump Election Effects on Financials

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4a2bb2aa-93db-424e-a3a9-b1ff00c6337b/transcript

TikTok’s likelihood of dodging a Jan. 19 effective ban in the US took a nosedive after a difficult Sept. 16 court hearing, according to Bloomberg Intelligence litigation analyst Matthew Schettenhelm. In this Votes and Verdicts Brief, he joins BI colleague Elliott Stein to discuss the hearing, what’s next in the case and how the issue is likely to be resolved, and why competitors like Meta and Alphabet might benefit.

TikTok’s likelihood of dodging a Jan. 19 effective ban in the US took a nosedive after a difficult Sept. 16 court hearing, according to Bloomberg Intelligence litigation analyst Matthew Schettenhelm. In this Votes and Verdicts Brief, he joins BI colleague Elliott Stein to discuss the hearing, what’s next in the case and how the issue is likely to be resolved, and why competitors like Meta and Alphabet might benefit.

TikTok-Ban Risk Soars After Key Court Hearing

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/00d0222a-2691-4346-9b8c-b1f101353c15/transcript

Companies facing multibillion-dollar exposure from mass-tort personal-injury litigation have faced massive jury verdicts in 2024. In this Votes and Verdicts episode, BI litigation analyst Holly Froum is joined by mass-tort expert and attorney Joseph Fantini to discuss some of the major litigation facing consumer and industrial companies, including cancer claims against Bayer’s Monsanto weedkiller, Zantac lawsuits against drugmakers GSK and others, NEC litigation against Abbott and Reckitt’s Mead Johnson unit and PFAS cases against 3M and other manufacturers. They discuss potential catalysts, the strength of cases, as well as likelihood of potential global settlements.

Companies facing multibillion-dollar exposure from mass-tort personal-injury litigation have faced massive jury verdicts in 2024. In this Votes and Verdicts episode, BI litigation analyst Holly Froum is joined by mass-tort expert and attorney Joseph Fantini to discuss some of the major litigation facing consumer and industrial companies, including cancer claims against Bayer’s Monsanto weedkiller, Zantac lawsuits against drugmakers GSK and others, NEC litigation against Abbott and Reckitt’s Mead Johnson unit and PFAS cases against 3M and other manufacturers. They discuss potential catalysts, the strength of cases, as well as likelihood of potential global settlements.

Bayer, Abbott Billion-Dollar Mass-Tort Risk

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6b063dd8-7b11-47a5-8f18-b1e901138f22/transcript

Tiger Money (Sponsored Content)

In 1 playlist(s)

Votes & Verdicts

Social links

Follow podcast

Recent clips